Announcements

9 December 2025
Meet Us at the 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka), 26–29 March 2026, Osaka, Japan


Conference: The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Date: 26–29 March 2026
Location: Osaka, Japan

MDPI will be attending the 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka) as an exhibitor, which will be held from 26 to 29 March 2026, and we welcome researchers from diverse backgrounds to visit and share their latest ideas with us.

Pharmaceutical sciences are comprehensive sciences that require expertise from a wide range of academic fields, including physics, chemistry, biology, medical sciences, and clinical sciences. In order to overcome the various challenges surrounding pharmaceutical sciences today, cross-disciplinary collaboration beyond traditional boundaries has become increasingly important and will be emphasized and discussed during the 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka).

The conference is organized by the Pharmaceutical Society of Japan and chaired by Prof. Takashi Ohshima from the Graduate School of Pharmaceutical Sciences, Kyushu University. The theme is Promoting the Ecosystem in Pharmaceutical Sciences: Future Innovation through Cross-disciplinary Collaboration. This conference will bring together around 5,000 scientists and students to share research advances covering a wide range of scientific topics. The sessions include, but are not limited to, the following: (1) Pharmaceutical Chemistry; (2) Pharmaceutical Physics; (3) Pharmaceutical Biology; (4) Pharmaceutical Health Science and Environmental Toxicology; (5) Pharmaceutical Health Care and Sciences; and (6) Others.

The following MDPI journals will be represented at the conference:

  • Pharmaceuticals;
  • Diseases;
  • Pharmacy;
  • Applied Biosciences;
  • Antibodies;
  • Biomedicines;
  • Future Pharmacology;
  • JPBI;
  • JPM;
  • Marine Drugs;
  • Medicines;
  • Pharmaceutics;
  • Pharmacoepidemiology.
If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://pub.confit.atlas.jp/en/event/pharm146.

6 November 2025
MDPI Launches the Michele Parrinello Award for Pioneering Contributions in Computational Physical Science


MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.


About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.


Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process.

The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.


About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

2 March 2026
Meet Us at the Human Genome Meeting 2026, 21–24 April 2026, Athens, Greece


Conference:
Human Genome Meeting 2026.
Organization: Human Genome Organization (HUGO).
Date: 21–24 April 2026.
Place: Athens, Greece.
Booth: #8.

MDPI journals will be attending the Human Genome Meeting 2026 as an exhibitor. The Human Genome Meeting 2026 will be held on April 22nd to 24th, 2026, in Athens, Greece, with a pre-day trainee symposium on April 21st. The theme of the HGM2026, “Bringing our Genomes to Medicine”, reflects the focus on various aspects of genome-stratified medicine and therapeutic interventions, including but not limited to pharmacogenomics, polypharmacy, population genomics, large-scale sequencing projects, clinical implementation of personalized medicine interventions, genome informatics, public health genomics, ethics in genomics, health economics, and others. Drawing on a truly broad-reaching and international line-up of experts, HGM 2026 promises to be a dynamic forum for scientific exchange and a unique opportunity to unite global expertise all focused on the subject of “Personalized Medicine and Therapeutics— Improving health”.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth #8. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link: https://www.hugo-hgm2026.org/

28 February 2026
Journal of Personalized Medicine | Editor’s Choice Articles in Q4 of 2025


We are delighted to share some of the Editor’s Choice Articles that were published in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in Q4 of 2025. The full list can be viewed via the following link: https://www.mdpi.com/journal/jpm/editors_choice.

1. “Predicting the Onset of Diabetes with Machine Learning Methods”
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406
Available online: https://www.mdpi.com/2075-4426/13/3/406
Cited by 113 | Viewed by 12030+

2. “Advancing Patient Care: How Artificial Intelligence Is Transforming Healthcare”
by Diana Gina Poalelungi, Carmina Liana Musat, Ana Fulga, Marius Neagu, Anca Iulia Neagu, Alin Ionut Piraianu and Iuliu Fulga
J. Pers. Med. 2023, 13(8), 1214; https://doi.org/10.3390/jpm13081214
Available online: https://www.mdpi.com/2075-4426/13/8/1214
Cited by 114 | Viewed by 22095+

3. “The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration”
by Anna Pisani, Fabiola Paciello, Valeria Del Vecchio, Rita Malesci, Eugenio De Corso, Elena Cantone and Anna Rita Fetoni
J. Pers. Med. 2023, 13(4), 652; https://doi.org/10.3390/jpm13040652
Available online: https://www.mdpi.com/2075-4426/13/4/652
Cited by 72 | Viewed by 11520+

4. “Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence”
by Rosa Méndez Hernández and Fernando Ramasco Rueda
J. Pers. Med. 2023, 13(2), 333; https://doi.org/10.3390/jpm13020333
Available online: https://www.mdpi.com/2075-4426/13/2/333
Cited by 58 | Viewed by 10090+

5. “Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making”
by Sebastian Griewing, Niklas Gremke, Uwe Wagner, Michael Lingenfelder, Sebastian Kuhn and Jelena Boekhoff
J. Pers. Med. 2023, 13(10), 1502; https://doi.org/10.3390/jpm13101502
Available online: https://www.mdpi.com/2075-4426/13/10/1502
Cited by 57 | Viewed by 4875+

6. “Multi-Modal Stacking Ensemble for the Diagnosis of Cardiovascular Diseases”
by Taeyoung Yoon and Daesung Kang
J. Pers. Med. 2023, 13(2), 373; https://doi.org/10.3390/jpm13020373
Available online: https://www.mdpi.com/2075-4426/13/2/373
Cited by 54 | Viewed by 5310+

7. “Airway Management: The Current Role of Videolaryngoscopy”
by Sophie A. Saul, Patrick A. Ward and Alistair F. McNarry
J. Pers. Med. 2023, 13(9), 1327; https://doi.org/10.3390/jpm13091327
Available online: https://www.mdpi.com/2075-4426/13/9/1327
Cited by 51 | Viewed by 9790+

8. “State of the Art in Robotic Surgery with Hugo RAS System: Feasibility, Safety and Clinical Applications”
by Francesco Prata, Alberto Ragusa, Claudia Tempesta, Andrea Iannuzzi, Francesco Tedesco, Loris Cacciatore, Gianluigi Raso, Angelo Civitella, Piergiorgio Tuzzolo, Pasquale Callè et al.
J. Pers. Med. 2023, 13(8), 1233; https://doi.org/10.3390/jpm13081233
Available online: https://www.mdpi.com/2075-4426/13/8/1233
Cited by 45 | Viewed by 6725+

9. “Functional Alignment Philosophy in Total Knee Arthroplasty—Rationale and Technique for the Valgus Morphotype Using an Image Based Robotic Platform and Individualized Planning”
by Jobe Shatrov, Constant Foissey, Moussa Kafelov, Cécile Batailler, Stanislas Gunst, Elvire Servien and Sébastien Lustig
J. Pers. Med. 2023, 13(2), 212; https://doi.org/10.3390/jpm13020212
Available online: https://www.mdpi.com/2075-4426/13/2/212
Cited by 45 | Viewed by 9755+

10. “The Role of Uric Acid in Human Health: Insights from the Uricase Gene”
by Youssef M. Roman
J. Pers. Med. 2023, 13(9), 1409; https://doi.org/10.3390/jpm13091409
Available online: https://www.mdpi.com/2075-4426/13/9/1409
Cited by 42 | Viewed by 19190+

11. “Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer”
by Josephine B. Oehler, Weranga Rajapaksha and Hugo Albrecht
J. Pers. Med. 2024, 14(7), 723; https://doi.org/10.3390/jpm14070723
Available online: https://www.mdpi.com/2075-4426/14/7/723
Cited by 42 | Viewed by 10560+

12. “Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder”
by Anton Shkundin and Angelos Halaris
J. Pers. Med. 2023, 13(9), 1395; https://doi.org/10.3390/jpm13091395
Available online: https://www.mdpi.com/2075-4426/13/9/1395
Cited by 39 | Viewed by 7815+

13. “Intelligent Digital Twins for Personalized Migraine Care”
by Parisa Gazerani
J. Pers. Med. 2023, 13(8), 1255; https://doi.org/10.3390/jpm13081255
Available online: https://www.mdpi.com/2075-4426/13/8/1255
Cited by 39 | Viewed by 5930+

14. “Active Surveillance for Prostate Cancer: Past, Current, and Future Trends”
by Ivo I. de Vos, Henk B. Luiting and Monique J. Roobol
J. Pers. Med. 2023, 13(4), 629; https://doi.org/10.3390/jpm13040629
Available online: https://www.mdpi.com/2075-4426/13/4/629
Cited by 38 | Viewed by 7535+

15. “Three-Dimensional Accuracy and Stability of Personalized Implants in Orthognathic Surgery: A Systematic Review and a Meta-Analysis”
by Alexandru Diaconu, Michael Boelstoft Holte, Gabriele Berg-Beckhoff and Else Marie Pinholt
J. Pers. Med. 2023, 13(1), 125; https://doi.org/10.3390/jpm13010125
Available online: https://www.mdpi.com/2075-4426/13/1/125
Cited by 38 | Viewed by 5715+

16. “Leveraging Machine Learning for Personalized Wearable Biomedical Devices: A Review”
by Ali Olyanasab and Mohsen Annabestani
J. Pers. Med. 2024, 14(2), 203; https://doi.org/10.3390/jpm14020203
Available online: https://www.mdpi.com/2075-4426/14/2/203
Cited by 35 | Viewed by 15140+

17. “Epidemiology and Risk Factors of UTIs in Children—A Single-Center Observation”
by Maria Daniel, Hanna Szymanik-Grzelak, Janusz Sierdziński, Edyta Podsiadły, Magdalena Kowalewska-Młot and Małgorzata Pańczyk-Tomaszewska
J. Pers. Med. 2023, 13(1), 138; https://doi.org/10.3390/jpm13010138
Available online: https://www.mdpi.com/2075-4426/13/1/138
Cited by 35 | Viewed by 10865+

You can view the abovementioned articles and submit papers to JPM via the following link: https://www.mdpi.com/journal/jpm.

JPM Editorial Office

28 February 2026
MDPI INSIGHTS: The CEO’s Letter #32 - MDPI China and Thailand, China Science Daily, 1,000 Partnerships, R2R

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflections from China: Year-End-Celebrations and Open Access Publishing

In February, I had the pleasure of joining over a thousand colleagues from our Tongzhou and Haidian offices at their end-of-year annual celebration in Beijing.

Spending time with our teams in China is also a powerful reminder of the scale and complexity of MDPI as a global organization. Our colleagues in Beijing, Wuhan, and across the country play a significant role in our day-to-day operations and long-term development. I’m grateful for the hospitality, collaboration, and commitment shown by our managers and teams in China, alongside colleagues worldwide, who have helped steadily build MDPI, brick by brick, over the years.

Below are some data on Open Access (OA) publishing in China and our collaboration in this important research market.

Open Access Publishing in China

China has been the world’s leading country in research and review article publication volume since 2019, exceeding one million publications in 2025. Over the past five years, the gap between China and the second-ranked country, the United States, has continued to widen.

In 2025:

  • 47% of China’s research output was published Open Access
  • Of those OA publications, 76% were Gold Open Access (approximately 382,930 articles)
  • The overall OA distribution remained stable compared with 2024, with Gold OA increasing by 1%

Over the past five years (2021–2025):

  • China published 4,398,050 research and review articles
  • Approximately 48% of this output was OA

According to Dimensions, when comparing the top 20 countries by publication volume (2021–2025):

  • China ranks 1st worldwide in publication volume
  • China ranks 9th in citation performance within this group (for comparison, the US ranks 2nd in publication volume and 10th in citation ranking)
  • Average citations per article: 12.51

Among the top 10 universities globally by publication volume, six are Chinese institutions, alongside Harvard University (USA), the University of São Paulo (Brazil), the University of Toronto (Canada), and the University of Oxford (UK).

MDPI and China

China is an important and long-standing part of MDPI’s global publishing ecosystem:

  • In 2025, MDPI was the largest fully Open Access publisher in China
  • MDPI published 22% of China’s Gold Open Access output (82,133 papers)
  • We received 290,999 submissions from China-affiliated authors and published 82,133 articles
  • There are 8,500+ active Editorial Board Members based in China
    • 64% (5,438) have an H-index above 26
  • MDPI works with:
    • 117 Editors-in-Chief
    • 103 Section Editors-in-Chief
  • 71 China-based institutions currently hold IOAP agreements with MDPI, seven of which rank among the top 10 Chinese institutions by publication volume

China's scale in research output means that the publishing platforms chosen by Chinese scholars will continue to influence the direction of scholarly publishing. At the same time, MDPI’s strength comes from its international collaboration, with colleagues, editors, reviewers, and authors working together across regions and disciplines.

Thank you to all our colleagues in China, and around the world, who support MDPI’s publishing activities across departments and help advance open access research every day.

Impactful Research

“Progress in open science is built through trust, dialogue, and relationships”

Behind the Scenes: A Conversation with China Science Daily

During my trip to Beijing, I also had the opportunity to visit China Science Daily and take part in an interview and broader exchange with their team in Beijing. Visits like this matter because progress in open science is built not only through platforms and infrastructure, but also through trust, dialogue, and relationships across research communities and regions.

China Science Daily: History Museum

As part of the visit, I was given a tour of their History Museum, which offers a thorough perspective on the evolution of China’s first science and technology newspaper, established in 1959. The exhibition highlights how the organization developed into a trusted institution connecting research with the public and policymakers. It was a helpful reminder that at the core of publishing is stewardship, credibility, and long-term public engagement with science.

An Open Exchange on Open Science

During the visit, I met with Dr. Zhao Yan, Editor-in-Chief of ScienceNet. We had an open and engaging conversation about MDPI’s role in Open Access, the evolution of open science globally, and the potential for more collaboration going forward. He especially appreciated the candid and personal nature of our exchange, noting that this kind of dialogue feels important in a landscape where trust and transparency matter.

Interview on Open Access

I also participated in an interview with Ms. Yan Jie, from the Online Media Center and Editor-in-Chief of ScienceNet, China Science Daily. Our discussion covered the growth of Open Access over the past 30 years, MDPI’s mission and values, academic integrity, collaboration with the Chinese research community, and MDPI’s own 30th anniversary milestone. It was a great opportunity to reflect on how open science has matured, and where shared responsibility across publishers, institutions, and researchers continues to matter most.

“Progress in open science is built by more than scale and infrastructure”

I’m sharing a few photos from the visit as a glimpse behind the scenes. The full interview will be published by China Science Daily in due course, and I look forward to sharing it when it is available.

More broadly, visits like this reinforce something I’ve always believed in: progress in open science is built not only through scale and infrastructure, but also through continued dialogue, mutual respect, collaboration, and a willingness to listen across regions and perspectives. That remains central to our work, especially as MDPI reflects on 30 years of publishing, built together.

Inside MDPI

Bangkok Visit: Growth, Partnership, and Local Impact

In February, I also had the opportunity to visit our Bangkok office for the second time in two years to support their local meetings and deliver a training session on how we present MDPI at a corporate level.

It’s easy to spend time with our colleagues in Thailand. From Editorial and Production to Conferences, Marketing, Design, and our Regional Journal Relations Specialist (RJRS), the team continues to grow in scale and professionalism. I’d also like to recognize our local management and admin teams, who have been steadily expanding our office and supporting more than 500 colleagues on the ground.

Academic Partnerships

During the visit, we met with the Engineering Department at King Mongkut’s Institute of Technology Ladkrabang (KMITL). Our discussion focused on the recent MDPI developments, Institutional Open Access Program (IOAP) opportunities, Author Publishing Workshops (APW), and the potential use of JAMS to support their institutional journal.

“MDPI is the third-largest OA publisher in Thailand”

We also shared insights into the growth of Open Access (OA) in Thailand and KMITL’s own publishing trends. These conversations matter because institutions are looking for sustainable ways to support their researchers. Our IOAP agreements are one simple example of how we can provide value in this area while maintaining accessibility for authors.

Thailand and MDPI: 2025 Snapshot

Our Bangkok office, officially launched in 2022, has been growing to support over 500 staff members while continuing to expand its engagement in scholar visits, workshops, and conference collaborations. As at 2025, Thailand submissions to MDPI have increased about 21% and publications by about 25%, maintaining a rejection rate close to the company average. MDPI is the third-largest OA publisher in Thailand, publishing 15% of all Gold OA output in 2025.

Representing MDPI Externally

During the visit, I delivered a training session on how we present MDPI at external events.

This session covered topics related to:

  • Our aim and guiding principles
  • High-level company milestones and Indexing facts and figures
  • Industry partnerships and collaborations
  • Market trends in OA and subscription publishing
  • Country-specific publishing data and collaborations with MDPI
  • Insights from our Voice of Community report

I find that while many colleagues are very familiar with the specific journal for which they have responsibility, fewer have visibility into the broader MDPI ecosystem and the company’s global positioning. These sessions help build alignment, confidence, and consistency in how we represent the company.

What stands out most is that MDPI’s growth is not abstract: it’s visible in the people, the partnerships, and the professionalism developing across our offices.

Coming Together for Science

1,000 Institutional Partners: A Milestone Built on Trust

This month, we reached an important milestone: more than 1,000 institutions worldwide are now part of MDPI’s Institutional Open Access Program (IOAP). On paper, that is a number. In practice, it represents trust.

This milestone symbolizes thousands of conversations with libraries and institutions. It stands for negotiations, renewals, consortium expansions, and, most importantly, relationships built over time. It reflects the work of colleagues across publishing, institutional partnerships, marketing, editorial, finance, and many other teams who contribute to making these agreements operational.

In 2025 alone, more than 61,300 research articles benefited from article processing charge (APC) discounts through IOAP agreements. Tens of thousands of authors were able to publish through a simplified and structured process. At the same time, institutional administrators gained clearer oversight and streamlined workflows.

Why IOAP Matters

When we launched IOAP, the objective was straightforward: to reduce barriers for researchers while supporting institutions in navigating the evolving OA landscape. Over the past decade, the research ecosystem has changed. Funder mandates, national policies, and Plan S–aligned requirements have accelerated the transition to OA.

Institutions need publishing partners who provide transparency, scalability, and operational efficiency. IOAP was designed to support that reality.

For colleagues who would like to better understand the program, this blog-post overview of MDPI’s IOAP provides additional context, including common questions around the transition to OA and how our institutional partnerships are structured.

“Institutions need publishing partners who provide transparency, scalability, and operational efficiency”

Recent Examples

Our agreements continue to evolve across regions:

These examples show that institutions seek structured, predictable models that support their researchers at scale.

Looking Ahead

Crossing the threshold of 1,000 partners tells us that institutions see MDPI not just as a publisher but as a reliable operational partner in advancing open science. This milestone is not a finish line. It is a reminder that the work continues.

Thank you to the entire IOAP team and to all colleagues who contributed to reaching this achievement.

P.S. You can read about this milestone across industry outlets, including STM Publishing News, ALPSP, Research Information, EurekAlert, Brightsurf, among others. You can also read about the coverage in Poland (e.g., media-room, bomega) Korea (newstap), and Romania (EduLike).

Closing Thoughts

Reflections from the Researcher to Reader Conference

During 24–25 February, I attended the 2026 Researcher to Reader Conference in London, UK. Leaders from across scholarly publishing, research infrastructure, libraries, and technology gathered to discuss AI and research integrity, peer review reform, metadata and infrastructure, community engagement, open research policy, and the evolving role of publishers in a rapidly shifting ecosystem.

The conversations were open and honest, and at times uncomfortable – exactly what we need at times. Below are a few reflections that stayed with me.

The Battle for Knowledge: What Becomes Accepted as ‘True’?

One recurring theme was not whether science evolves but whether our infrastructure is resilient enough to sustain trust at scale. Science does not promise certainty: it promises process. As publishing systems grow more complex and become more technologically mediated, the question is how intentionally we design, monitor, and strengthen that process.

Peer Review: Speed, Credentials, and Structural Loops

Researchers consistently call for faster peer review. At the same time, reviewer credentials are often tied to publication records. This creates a structural loop. Publishing history opens reviewing opportunities, reviewing strengthens credentials, and those without early access remain outside the cycle.

There is a need for us to reflect on how opportunity circulates within our systems: we should ask how we create more inclusive pathways for researchers globally to participate in peer review.

Community Engagement Workshop

One of the highlights of R2R was the workshop format, whereby small groups met repeatedly over two days and moved from ideas to tangible strategies.

I joined the Community Engagement workshop led by Lou Peck (CEO at The International Bunch) and Godwyns Onwuchekwa (Principal Consultant at Global Tapestry Consulting). We explored two deceptively simple questions: What is a community? and What does engagement truly mean?

“Engagement requires shared design and shared responsibility”

Too often, organizations equate communication with engagement. The framework discussed mapped a maturity spectrum – from enablement (broadcasting, informing and consulting) to true engagement (collaborating and co-creating).

It was a useful reminder of the fact that if we want trust and loyalty, engagement must go beyond announcements and surveys. It requires shared design and shared responsibility.

AI: Democratization or Digital Colonialism?

I especially enjoyed the thought-provoking presentation from Nikesh Gosalia (Chief Partnership Officer at Cactus Communications), which highlighted an uncomfortable reality:

  • 93% of AI-generated content is in English
  • Approximately 2% is in French
  • Approximately 2% is in German
  • More than 7,000 languages are represented in less than 5% of the content within large AI systems

The implications are profound. Is AI democratizing access to scholarly publishing (making it easier for researchers everywhere to participate in global knowledge production)? Or are we encoding colonialism at scale (entrenching linguistic and structural hierarchies, and making it harder for voices from the Global South to be heard)?

AI is already reshaping how research is created, reviewed, discovered, and shared. Its potential is enormous. But its impact depends not only on capability, but on governance, design, and intentionality. Publishers, funders, and researchers all share responsibility in shaping how these systems evolve.

Ethicality in practice (Lightening Talk)

It was also great to have our colleague Dr Miloš Čučulović (Head of Technology Innovation at MDPI) present MDPI’s Ethicality platform during a lightning talk.

“Technology alone is not the answer”

Ethicality embeds AI-driven checks directly into the submission workflow, supporting editors proactively rather than reacting after publication. As we scale, tools like this help balance trust, efficiency, and research integrity.

This goes back into the underlying theme of the conference that technology alone is not the answer. However, technology embedded thoughtfully within clear governance frameworks can strengthen confidence in the editorial process.

Final thought

The question is no longer whether technology will transform research infrastructure: it is already doing so. The real question is what role each of us will play in shaping that transformation deliberately, with structural maturity, inclusive governance, and engagement that moves from informing to co-creating.

Science needs to evolve, responsibly. And that responsibility extends not only to what we publish, but also to how the systems behind publication are designed. Some important topics to continue reflecting on both internally and within our broader community.

Stefan Tochev
Chief Executive Officer
MDPI AG

27 February 2026
Journal of Personalized Medicine | Highly Viewed Papers in 2025 and Hot Topic Special Issues in the “Pharmacogenetics” Section


We are thrilled to share some of the highly viewed papers in the section “Pharmacogenetics” that were published in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in 2025. In addition, some Special Issues in this section are open for submission. The following is a list of articles and Special Issues that we believe will be of interest to you.

The highly viewed articles are as follows:

1. “Major Allele Frequencies in CYP2C9 and CYP2C19 in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial Categories”
by Horng-Ee Vincent Nieh and Youssef Malak Roman
J. Pers. Med. 2025, 15(7), 274; https://doi.org/10.3390/jpm15070274
Available online: https://www.mdpi.com/2075-4426/15/7/274

2. “Clinician Experiences at the Frontier of Pharmacogenomics and Future Directions”
by Stefan Thottunkal, Claire Spahn, Benjamin Wang, Nidhi Rohatgi, Jison Hong, Abha Khandelwal and Latha Palaniappan
J. Pers. Med. 2025, 15(7), 294; https://doi.org/10.3390/jpm15070294
Available online: https://www.mdpi.com/2075-4426/15/7/294

3. “Implementation of Pharmacogenomics Testing in Daily Clinical Practice: Perspectives of Prescribers from Two Canadian Armed Forces Medical Clinics”
by Alexandra Muller-Gass, Gouri Mukerjee, Ruslan Dorfman and Rakesh Jetly
J. Pers. Med. 2025, 15(3), 101; https://doi.org/10.3390/jpm15030101
Available online: https://www.mdpi.com/2075-4426/15/3/101

4. “Impact of Complex Genetic and Drug–Drug Interactions on Tamoxifen Metabolism and Efficacy”
by Ibtissam Saad, Kaoutar Bentayebi, Soukaina Ettoury, Oumaima Zarrik, Ilhame Bourais, Saber Boutayeb, Caroline Samer, Youssef Daali, Rachid Eljaoudi and Sara Louati
J. Pers. Med. 2025, 15(11), 505; https://doi.org/10.3390/jpm15110505
Available online: https://www.mdpi.com/2075-4426/15/11/505

5. “Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine”
by Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Emilio Fernández-Varón, Alicia Torres-García, Isabel Blancas, José Cabeza-Barrera and Rocío Morón
J. Pers. Med. 2025, 15(6), 245; https://doi.org/10.3390/jpm15060245
Available online: https://www.mdpi.com/2075-4426/15/6/245

6. “Enhancing Rural Healthcare Accessibility: A Model for Pharmacogenomics Adoption via an Outreach-Focused Integration Strategy”
by Jared Silver, Evan Forman, David Barrett, Jovana Sibalija and Richard Kim
J. Pers. Med. 2025, 15(3), 110; https://doi.org/10.3390/jpm15030110
Available online: https://www.mdpi.com/2075-4426/15/3/110

7. “Exploring the Clinical Workflow in Pharmacogenomics Clinics: An Observational Study”
by Nicole Keuler, Jane McCartney, Renier Coetzee and Rustin Crutchley
J. Pers. Med. 2025, 15(4), 146; https://doi.org/10.3390/jpm15040146
Available online: https://www.mdpi.com/2075-4426/15/4/146

8. “Pharmacogenomics in Diabetes: Population-Specific Insights from Colombia”
by David A. Hernandez-Paez, Johana Galván-Barrios, Kevin Fernando Montoya-Quintero and Indiana Luz Rojas Torres
J. Pers. Med. 2025, 15(10), 481; https://doi.org/10.3390/jpm15100481
Available online: https://www.mdpi.com/2075-4426/15/10/481

Special Issues:

New Trends and Challenges in Pharmacogenomics Research
Guest Editor: Prof. Dr. Youssef Roman
Submission deadline: 31 May 2026
Advances in Physiologically Based Pharmacokinetics
Guest Editors: Dr. Rodrigo Cristofoletti and Dr. Janny Piñeiro-Llanes
Submission deadline: 20 June 2026

You are invited to view the above-mentioned articles and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/jpm.

JPM Editorial Office

20 February 2026
MDPI Virtual Academic Publishing Workshop (New Harvest), 25 February 2026


This Academic Publishing Workshop will be led by MDPI Regional Journal Relations Specialist, Dr. Sally Wu, on “Author Training”. Participants will receive practical advice on essential aspects of writing academic articles. Participants will leave with a clearer understanding of the academic publishing landscape and how to successfully contribute to it.

Date: 25 February 2026
Time: 11:30 a.m.–1:30 p.m. EST

Schedule:

Speaker

Program

Time in EST

Dr. Sally Wu

Introduction

11:30–11:40 a.m.

Dr. Sally Wu

Tips for Writing Great Research Papers

  • Structuring a research paper
  • Tips for every section of a research paper
  • Q&A Session

11:40 a.m.–12:15 p.m.

Dr. Sally Wu

How to Respond to Peer Reviewers

  • Peer Review Reports
  • Examples of Response to Reviewers
  • Q&A Session

12:15–12:50 p.m.

Dr. Sally Wu

AI in Publishing: Challenges and Opportunities

  • AI in scientific publishing
  • How to use AI ethically
  • Q&A Session

12:50–13:30 p.m.

Speakers:

Dr. Sally Wu received a PhD in medical science from the University of Toronto in the fall of 2025. She joined MDPI in February 2025 as an Assistant Editor for Cells. She was recently promoted to Regional Journal Relations Specialist position in August. In this role, she works with many journals, liaising with authors, board members, and EiCs. She has attended several conferences across North America, hosted scholar visits, and taken part in other outreach events.

18 February 2026
Acknowledgment to the Reviewers of Journal of Molecular Pathology in 2025


The editorial office of Journal of Molecular Pathology (JMP) would like to extend its sincere gratitude to all reviewers who contributed to the improvement of the journal quality by providing their expert opinion and evaluation of the submitted research.

We appreciate that thorough peer review demands considerable time and intellectual investment from our reviewers. In 2025, JMP received 223 review reports from contributors across 34 countries and territories, demonstrating the breadth of international expertise and scholarly engagement that has strengthened our publication standards.

The reviewers who agreed to have their names published this year are listed below in alphabetical order by first name. The editorial team acknowledges with gratitude all reviewers, named and anonymous alike, for their vital role in maintaining the scholarly standards of JMP.

Airat Bilyalov John Dotis
Aldona Kasprzak José Carlos De La Flor
Anto Sam Crosslee Louis Sam Titus Jumari Snyman
Bangyuan Wu Jung-Tae Lee
Bo Li Kohei Funasaka
Carla Miranda Matvey M. Tsyganov
Eduardo López-Urrutia Michele Cennamo
Fan Tang Mohammad Hasanain
Fernando Javier Barreyro Oleg M. Demchuk
Francisco J. del Castillo Panagiotis Mallis
Gabriele Napoletano Paolo Fagone
Gianluca Baldanzi Richard John Bruce Francis
Giulia Valentini Roman Moskalenko
Giuseppe Losurdo Rossella Melcarne
Hector Ivan Saldivar Ceron Sahiti Chukkapalli
Howard Lopes Ribeiro Junior Simona De Summa
Jasenka Wagner Stefano Stracquadanio
Jerzy Tadeusz Chudek Tahir Cetin Akinci
Jianzhu Liu Vincenzo Cuteri
Jinwen Kang Zhen Li

18 February 2026
MDPI’s Open Access Program Reaches 1,000 Institutions Worldwide

MDPI has surpassed the milestone of 1,000 partners within the Institutional Open Access Program (IOAP). The agreements span 59 countries, covering North and South America, Europe, Asia, Africa, and Oceania.

Last year alone, more than 150 new libraries and academic institutions joined MDPI’s IOAP. With the expansion of an existing consortium deal in Sweden we welcomed a further 75 partners to the program in January 2026, enabling us to surpass the 1,000-partners milestone.

The IOAP supports affiliated researchers by streamlining submission processes, reducing administrative burdens, and offering discounted Article Processing Charges (APCs). Through IOAP membership, more than 61,300 research articles received APC discounts in 2025, driving greater visibility and accessibility for partner institutions and global research communities alike.

"This milestone marks a significant step towards expanding MDPI’s global impact," said Stefan Tochev, MDPI's CEO. "Reaching 1,000 IOAP partnerships is a true testament to the growing trust and collaboration we’ve built with universities, libraries, and research organizations worldwide. We are proud to lead the way in Open Access publishing, ensuring researchers have the support they need to reach global audiences." "The success of our program is reflected in the growing global demand for Open Science and quality publishing services," said Becky Castellon, MDPI institutional partnerships manager. "Equally, institutions are increasingly seeking Open Access publishing options that support funder and national mandates. Joining the IOAP makes compliance simple."

3 February 2026
Acknowledgment to the Reviewers of Journal of Personalized Medicine in 2025


The editorial office of Journal of Personalized Medicine would like to extend its sincere gratitude to all reviewers who contributed to the improvement of the journal quality by providing their expert opinion and evaluation of the submitted research.

We appreciate that thorough peer review demands considerable time and intellectual investment from our reviewers. In 2025, Journal of Personalized Medicine received 3213 review reports from contributors across 82 countries and territories, demonstrating the breadth of international expertise and scholarly engagement that has strengthened our publication standards.

The reviewers who agreed to have their names published this year are listed below in alphabetical order by last name/first name. The editorial team acknowledges with gratitude all reviewers, named and anonymous alike, for their vital role in maintaining the scholarly standards of Journal of Personalized Medicine.

Abdolreza Jamilian

Giuliano Anastasi

Muntean Calin

Abel Lerma

Giulio Cirignaco

Murat Koklu

Abiola Victor Adepoju

Giuseppe Losurdo

Mustafa Busuladžić

Ach Taieb

Giuseppe Mincolelli

Nadine Darwiche

Adam Daniel Durma

Giuseppe Verolino

Nadir Yalcin

Adam Gędek

Godfrey Mutashambara Rwegerera

Nanush Damarlapally

Adina Braha

Gokul Patil

Naofumi F Sumitomo

Aditya Yashwant Sarode

Grigorios Kastanis

Nardi Tetaj

Adrián Hernández-Díazcouder

Guilherme Welter Wendt

Narendran Pradeep Kumar

Adriana Grigoraș

Gulali Aktas

Narongchai Autsavapromporn

Advait Vasavada

Hammad A Ganatra

Nasuh Utku Dogan

Afshana Quadiri

Hans-Oliver Rennekampff

Natasha J. Petry

Agamemnon Bakakos

Haowei Tai

Nathalie Vionnet

Agata Tarkowska

Hasan Çağrı Yıldırım

Nezar Watted

Agostino Fernicola

Hassan Rasouli

Nikias Milaras

Ahmad R. Alsayed

Hatem A. Alhadainy

Nikolaos Miaris

Ahmed Elfana

Hathal Haddad

Nikolaos Zavras

Ahmed Elsaftawy

Hazem El Beyrouti

Nina Mendez-Dominguez

Ahmed Mohsen

Hector Ivan Saldivar Ceron

Nora Hosny

Alberto Arezzo

Héctor Quezada

Normand García-Hernández

Alejandro Cano-Villagrasa

Hedley Knewjen Quintana

Nuria Paz Torres-Aguila

Aleksandar Jakovljević

Hiam Alquran

Oana Timofte

Alen Rončević

Hodaka Fujii

Olgica Nedic

Alexander E. Berezin

Howard Lopes Ribeiro Junior

Ömer Faruk Çiçek

Alexandra Eleftheria Menni

Hristina Zlatanova-Tenisheva

Osama B Mohammed

Alexandru Dan Costache

Hsuan-Hsiang Chen

Oveis Pourmehran

Alexandru Ulici

Husam Qanash

Ozlem Evren Kemer

Alexis Murillo Carrasco

Hüseyin Üzen

Pablo Díaz-Calvillo

Alin Horatiu Nedelcu

Iain A Rankin

Pablo Santamarina-Ojeda

Amalia Cornea

Ian Burgess

Paolo Scanagatta

Amira J. Zaylaa

Ibrahim Cil

Paraschiva Chereches-Panta

Amit Hudgi

Ignacio García-Gil

Parasuraman Subramani

Amr Seifelnasr

Ilia Kostadinov

Parisa Kaviani

Anastasia Spiliopoulou

Ilze Beitane

Parwis Massoudy

Anastasios Potiris

Ina Sevic

Patrizia Garbati

Andari Sarasati

Ingrid Fricke-Galindo

Patrycja Kleczkowska

Anderson Bermon

Inna Tulaeva

Patryk Szymaszek

András Molnár

Ioannis Dimakos

Paulo André Freire Magalhães

André Araújo Pinto

Ioannis Drygiannakis

Pedro Camacho

Andre Luiz Ferreira Costa

Ioannis G. Katsantonis

Pedro Moltó-Balado

Andrea Carugno

Ioannis Katsaros

Pedro Serralheiro

Andreas Antzoulas

Ioannis Michelakis

Petar Ozretić

Andreas M. Matthaiou

Iva Lakic

Peter Kokol

Andreea-Raluca Szőke

Ivana Bozic Antic

Peter Piko

Andrei Marian Feier

Ivana Medvedec Mikic

Phu Dinh Hoang

Andres Camargo-Sanchez

Ivica Bosnjak

Phuc Nhon Nguyen

Andrey Elchaninov

Iyad Naeem Muhammad

Pier Paolo Piccaluga

Andrijana Stanisavljević Ilić

Izabel Cristina Rodrigues Da Silva

Pilar Merino-Sanz

Angelica Quercia

Jakov Ajduk

Pinelopi Samara

Angeliki Gerede

Jakub Kufel

Piotr Sobolewski

Angelo Cianciulli

Jakub Mlodawski

Prabir Kumar Gharai

Anna Kawiak

Jakub Smiechowicz

Pratibha Gopalkrishna

Anna Rogozińska-Pawełczyk

Jaldeep Langhnoja

Predrag Jancic

Antonio Barbato

James C. L. Chow

Predrag Nikic

Antonio G. Lentoor

Jan Francesco Arena

Priya Upadhyay

António Miguel Morgado

Jan Žatecký

Qi Shao

Antonio Romanelli

Janusz Książyk

Qingsong Pang

Antonios I. Christou

Jędrzej Chrzanowski

Radu Andrei Moga

Ao Zhang

Jelena Jadzic

Rafael Bayareh Mancilla

Arjun Pon Avudaiappan

Jelena Janković Miljuš

Rafat Ghanamah

Arkadiusz Kocur

Jelena Jelena Nikolic

Raghunadharao Digumarti

Arrvind Raghunath

Jelena Of Kuvač Kraljević

Rahul Shivaji Patil

Arsen Uvelin

Jelena Vekic

Rakesh Kumar

Arvind Mukundan

Jesus Jonathan García-Galindo

Rakhee Rathnam Kalari Kandy

Ashot Avagimyan

Jincheng Wang

Raluca Isac

Athanasios A. Panagiotopoulos

Jinfeng Liu

Raluca Simona Costache

Athanasios G. Pantelis

João José Joaquim

Raluca Tatar

Atrayee Ray

Johannes Gerb

Ram B Singh

Aynur Aliyeva

Jolanta Szymańska

Rami Mahfouz

Azna Zuberi

Jonathan Soldera

Ramkumar Kunka Mohanram

Bahadar S Srichawla

Jorge Góngora Rodríguez

Raquel Medina-Ramírez

Ballambhattu Vishnu Bhat

José Ángel Rubiño-Díaz

Rawan Rumman

Balti Ala

Jose Antonio Velázquez-Aragón

Ray Lee

Barbara Sanchez-Dengra

José J. Leija-Martínez

Recep Dokuyucu

Bas Labree

José Manuel Rodríguez-Pérez

Renata Curić Radivojević

Basil Barth Duwa

Jose R. Guzman-Sepulveda

Renhao Lu

Begum Dariya

Joshua Sparks

Revaz Solomonia

Bernadette Kálmán

Josip Andelo Borovac

Ricardo Cleto De Sousa Marinho

Bhuvanesh Yathavan

Jovana Despotović

Ricardo D. Coletta

Bilal El-Mansoury

Juan Carlos Muñoz-Escalante

Richard Tóth

Bodhayan Prasad

Juan Gerardo Reyes-García

Rima Anggrena Dasrilsyah

Bogdan Florin Toma

Juan Luis Chávez Pacheco

Rita Kiss

Bogna Grygiel-Górniak

Juan Luis Rodriguez Hermosa

Ritthideach Yorsaeng

Bojan Stojanovic

Juan Manuel Guzman-Flores

Robert Alexandru Barna

Bruno Goncalves

Juan Torres Melero

Roberto Lazzarini

Bruno Vidaković

Judit Reka Hetthessy

Roberto Lugo

Burak Tasci

Julio Alberto García-Rodríguez

Rocco De Vitis

Byeong Geun Kim

Jun Thorsteinsdottir

Rodrigo Galo

Carla Giuseppina Corti

  1. B. V. Brahma Rao

Rodrigo Pardo-Turriago

Carlos Eric Galván-Tejada

  1. Sreedhara Ranganath Pai

Romil Parikh

Carlos Izaias Sartorão Filho

Kadir Uludag

Roselena Silvestri Schuh

Carmelina Cristina Zirafa

Kamal Sharma

Ruby Gupta

Carmelina Ruggiero

Kamil Koszela

Rudolf Lampé

Carmen Giuglea

Kana Fujikura

Rui Antunes Viana

Carmen Ortiz

Kanokwan Kulprachakarn

Rumen Stefanov Filev

Carolina L. Mercado

Karen A. Boehme

Ryuichi Ushijima

Catalina Ramírez-Contreras

Karmela Barisic

Sabina Galiniak

Celine Chaaya

Katarzyna Mądra-Gackowska

Sachin Kumar

Chanda Simfukwe

Katarzyna Zorena

Sachio Takeno

Chandra Mohan Reddy Muthumula

Katsushi Takebayashi

Said El-Ashker

Charalampos Karachalios

Kenji Hayashida

Sally Atef Fahim

Charalampos Thomas

Kenji Ibayashi

Saloua Mrabet

Chenyu Huang

Khashim Khashim

Salvatore Giordano

Chiara Maria Grana

Klaus Schomäcker

Samit Kumar Ghosh

Chien-Jen Hsu

Konstantinos Sidiropoulos

Sandeep Moothedath Subrahmanian

Chloe Lahoud

Konstantinos Tigkiropoulos

Sandra Modlińska

Chonnakarn Jatchavala

Kosuke Kojo

Sandra S Stinnett

Christian Messina

Krishna Priya Syama

Sang Hoon Oh

Christian Schach

Krystina Choinski

Sanja Kostic

Christoph Frank Dietrich

Laura Balanescu

Sasho Stoleski

Christos Fragoulis

Laura Rehak

Sebastjan Bevc

Christos Kyriakopoulos

Lavinia Alexandra Moroianu

Seeprarani Rath

Cinzia Marinaro

Lavinia Rech

Selene M Garcia-Luna

Ciprian Andrei Coroleuca

Lenka Lhotska

Semra Bilaçeroǧlu

Clarissa Willers

Leszek Szalewski

Sen Zhang

Claudia Brogna

Letizia Perillo

Seongmin Kim

Claudia Crescio

Lidija Savić

Serap Özer Yaman

Claudia Fernandez-Alarcon

Lidija Tulic

Seren Başaran

Claudio Terraza

Liton Devanth

Sergio Martinez-Huenchullan

Constantinos Chaniotakis

Livia Ionela Bobu

Setondji Cocou Modeste Alexandre Yahouédéhou

Constantinos M. Koutsojannis

Liviu Macovei

Seyed Mohamadmehdi Moshtaghion

Cosmin Ioan Faur

Loai A Shakerdi

Shai Elliot Nkoana

Cristian Gutu

Loai Shakerdi

Shehwaz Anwar

Cristian Ionut Orasanu

Lokesh Manjani

Shekhrajka Shekhrajka

Cristian Iuliu Mihail Iorga

Lord Jephthah Joojo Gowans

Shivani Ror

Cristian Trambitas

Lorenzo Caruso

Shuntaro Obi

Cristina Florescu

Lorenzo Malatino

Silviu Albu

Cristina Grosu

Luca Camoni

Silviu Cristian Voinea

Cristina Mihaela Ghiciuc

Luca Zanella

Simran Maggo

Cristina Tudoran

Lucilene Arilho Ribeiro-Bicudo

Soedarsono Soedarsono

Cyrus Motamed

Ľudmila Majerníková

Sofian Al Shboul

Daisuke Inoue

Ludovica Battilocchi

Song Peng Ang

Damir Vučinić

Luis Eduardo Almeida

Sorabh Kapoor

Dan Alexandru Cozac

Luise Schäfer

Soraia Pinto

Dan Cristian Manescu

Luka Bulić

Souvagya Panigrahi

Dana Emilia Movila

Luka Šimunović

Sreenija Yarlagadda

Daniel B Hier

Lusi Zhang

Stefano Mancin

Daniel Miron Brie

Madiha Javeed

Stergios Boussios

Daniel Osmar Suárez-Rico

Magdalena Iuliana Rufa

Stipe Ćorluka

Daphne Citherlet

Mahyar Daskareh

Suash Sharma

Dariusz Wojciech Mazurkiewicz

Maja Zoran Stefanović

Sudarshan Bhattacharjee

David B Sachar

Majed Odeh

Suguru Yokoo

Dawei Ge

Małgorzata Anna Poręba

Sulagna Sanyal

Delia Giovanniello

Manav Jain

Sumesh Sasidharan

Dennis Demedts

Manolis Abatzis-Papadopoulos

Suthat Chottanapund

Despoina Pantazi

Manuele Cesare

Swastik Phulera

Deyan Yordanov Yosifov

Marcel Firlej

Swati Dahariya

Diana Mitkova Hristova

Marcin Sadlocha

Syama Krishnapriya

Diego Dantas

Márcio De Carvalho Formiga

Syed Haris Omar

Diego Primavera

Maria Kapritsou

Syed Ibrar Hussain

Diego Sangiorgi

Maria Piedad Ussetti Gil

Sylvester Ifeanyi Omoruyi

Dileep Radhamony Amma (Nair)

Maria Theodoratou

Szederjesi Janos

Dimitrina Georgieva Miteva

Marianna Hall

Szu-Chia Liao

Dimitrios Varvoglis

Marija Paunovic

Taha Koray Sahin

Dimitris Miliopoulos

Marija S. Milic

Tahir Yagdi

Dimosthenis Lykouras

Marin Ogorevc

Tahir Yusuf Noorani

Dinesh Kumar Thekkinkattil

Mario Cantó Cerdán

Takao Kimura

Doha Mohamed

Mario Ganau

Tamara Vagg

Dong Qiu

Marios Spanakis

Tarik Kivrak

Donovan J. Peña-Montes

Marius Militaru

Teodora Telecan

Dorota Formanowicz

Marko Baralić

Thawatchai Phaechamud

Dr Mohammad Mofatteh

Marko Spasic

Theodoros Spinos

Dragana Filipovic

Marko Tarle

Theofanis Vavilis

Dragana M. Stanojevic

Markus Gesslein

Thomas Pincez

Dragica Selakovic

Marta Aleksandra Kwiatkowska

Tomasz Potaczek

Eleftherios P. Pappas

Marta Forte

Tomislav Kuzman

Elisa Duranti

Marton Keszthelyi

Toshiyuki Kawai

Elissavet Anestiadou

Mary J. Van Schooneveld

Tuğba Kuru Çolak

Elżbieta Grześk

Masafumi Itoh

Tugrul Elverdi

Emiel F.M. Wouters

Masahiro Iinuma

Valentin Puiu Chioncel

Emilie Vomhof-Dekrey

Matheus Vernet Machado Bressan Wilke

Valeria Marques Ferreira Normando

Emmanouil Ioannis Kapetanakis

Matjaž Kopac

Varvara Giuseppe

Emmanouil Karampinis

Matjaž Kopač

Vasileios Sousonis

Emmanouil M. Xydias

Matteo Riccò

Vasileios Tsagkalidis

Enita Nakas

Matthew Field

Vassilios Panoutsakopoulos

Erika Cvetko

Maurizio Stella

Vessela Krasteva

Erika Rangel

Mauro Lombardo

Veysel Umman

Eva Molina-Trinidad

Mauro Namías

Víctor Hugo Oidor-Chan

Evan Leibner

Mauro Parozzi

Vinay Kumar Sharma

Fabio Vistoli

Maximilian Scheer

Virgiliu Mihail Prunoiu

Fahd Kuriri

Mayank Gautam

Viswas Raja Solomon

Fatin Jannus

Mayuri Mudgal

Viviana Onofrei Aursulesei

Felipe Alckmin Carvalho

Md Daud Mohd Khairi

Vlad Dima

Felipe Leite Oliveira

Md. Aktaruzzaman

Vlad Horia Schitcu

Felix J. Klimitz

Mehmet Kaya

Vlad-Ionuț Nechita

Fengyang Huang

Mehmet Yigit Akgun

Vrinda Gote

Filip Pilipovic

Michael W Vannier

Wankyu Eo

Filippo Zilio

Michail Galanis

Warawut Chaiwong

Filippos Gerasimos Filippatos

Michelangelo Luciani

Wasifa Naushad

Fiona Healy

Michele Wyler

Wei Boon Yap

Florian Dudde

Miguel Castelo-Branco

Wiktor Stopyra

Florin Filip

Miguel Olivas

Wongthawat Liawrungrueang

Florin Leontin Lazar

Mihaela Ionica

Xianyang Liu

Francesco Maruccia

Mihaela Pertea

Xiao Jian Tan

Francisco García Sánchez

Mihail Lazar Mioc

Yana Gvozdeva

Francisco José Barbas Rodrigues

Mihalj Poŝa

Yanning Zuo

Francisco Rivas García

Mikhail Kulyabin

Yannis Mantas Paulus

Francisco Tustumi

Milan Toma

Yasin Yilmaz

Franklin Parrales Bravo

Milena Georgieva

Yeuan Ting Lee

Gabriel Magrin

Min Ho Kang

Yi Cheng Wu

Gabriel Mihail Dimofte

Ming-Chi Lu

Yi-Hsin Chen

Gabriela Goujgoulova

Ming-Hui Hung

Ying Li

Gaelle Hayot

Mircea Stoian

Ying Wang

Garri Chilingaryan

Mladen Marinkovic

Ylenia Cendon Florez

Gazmend Temaj

Mohamed Hany

Young Hwii Ko

Geer Teng

Mohammad Mofatteh

Yousef Tanas

George Doumat

Mohammad Mohabbulla Mohib

Youssef El Sayed Ahmad

Geovane Dias Lopes

Mohammad Qneibi

Yuan Chai

Geraldo Magela Magela Salomé

Mohammad Sarif Mohiuddin

Yuliya Semenova

Giacomo Bortolussi

Moisés León-Ruiz

Yuta Norimatsu

Gianluca Pagnoni

Monika Grudzinska Pechhacker

Zenon Pogorelić

Gianmarco Lazzini

Monika Kaurav

Zhiyuan Yang

Giovanni Corrado

Mor Rittblat

Zorana Dobrijević

Giovanni Mazzucato

Moumita Chakraborty

Zulkif Tanriverdi

Gisele Silvestre Da Silva

Mounika Angirekula

Back to TopTop